185
Participants
Start Date
December 31, 2016
Primary Completion Date
July 17, 2019
Study Completion Date
July 17, 2019
CYP2C19 genotyping
All proton pump inhibitors are metabolized in part by the CYP2C19 enzyme, which is encoded by the highly polymorphic CYP2C19 gene. Based on variations within this gene the effectiveness of the drug may be reduced.
University of Florida, Gainesville
Nemours Children's Hospital, Orlando
Nemours Children's Hospital
OTHER
National Human Genome Research Institute (NHGRI)
NIH
University of Florida
OTHER